TARGETING FANCD2 TRAFFICKINGAS A NOVEL STRATEGY FOR TREATMENT OF OVARIAN CANCER

被引：0
|
作者：
Pejovic, T. [1 ]
Schloff, E. [1 ]
Moffitt, M. [1 ]
De Geest, K. [1 ]
Mhawech-Fauceglia, P. [2 ]
机构：
[1] OHSU, Ob Gyn, Portland, OR USA
[2] Univ So Calif, Pathol, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1551
引用
收藏
页码：1468 / 1468
页数：1
相关论文
共 50 条
  • [41] Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment
    Yesheng Yin
    Qianqian Zhu
    Tianxia Jiang
    Libin Fan
    Xiaobo Qiu
    Science China(Life Sciences) , 2019, (08) : 1078 - 1086
  • [42] A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage
    X Chen
    L Bosques
    P Sung
    G M Kupfer
    Oncogene, 2016, 35 : 22 - 34
  • [43] Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer
    Wang, Meng
    Medeiros, Bruno C.
    Erba, Harry P.
    DeAngelo, Daniel J.
    Giles, Francis J.
    Swords, Ronan T.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 253 - 264
  • [44] 2′-Hydroxyflavanone: A novel strategy for targeting breast cancer
    Singhal, Jyotsana
    Nagaprashantha, Lokesh
    Chikara, Shireen
    Awasthi, Sanjay
    Horne, David
    Singhal, Sharad S.
    ONCOTARGET, 2017, 8 (43) : 75025 - 75037
  • [45] Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke, Wolfram C. M.
    Uciechowski, Peter
    Fenchel, Klaus
    Chevassut, Timothy
    ONCOLOGY, 2018, 95 (05) : 257 - 269
  • [46] FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability
    Liu, Wenpeng
    Polaczek, Piotr
    Roubal, Ivan
    Meng, Yuan
    Choe, Won-chae
    Caron, Marie-Christine
    Sedgeman, Carl A.
    Xi, Yu
    Liu, Changwei
    Wu, Qiong
    Zheng, Li
    Masson, Jean-Yves
    Shen, Binghui
    Campbell, Judith L.
    NUCLEIC ACIDS RESEARCH, 2023, 51 (17) : 9144 - 9165
  • [47] FANCD2 mRNA Overexpression is a Bona Fide Indicator of Lymph Node Metastasis in Human Colorectal Cancer
    Ozawa, Heita
    Iwatsuki, Masaaki
    Mimori, Koshi
    Sato, Tetsuya
    Johansson, Fredrik
    Toh, Hiroyuki
    Watanabe, Masahiko
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2341 - 2348
  • [48] A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage
    Chen, X.
    Bosques, L.
    Sung, P.
    Kupfer, G. M.
    ONCOGENE, 2016, 35 (01) : 22 - 34
  • [49] Targeting mTOR by a New Generation of Kinase Inhibitors Sensitizes Leukemia Cells for Chemotherapy Via Suppressing FANCD2 Expression
    Li, Jie
    Guo, Fukun
    Sipple, Jared
    Kozma, Sara
    Thomas, George
    Zheng, Yi
    Pang, Qishen
    BLOOD, 2011, 118 (21) : 657 - 657
  • [50] Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents
    Wang, Gui-Zhen
    Liu, Yong-Qiang
    Cheng, Xin
    Zhou, Guang-Biao
    CANCER SCIENCE, 2015, 106 (07) : 902 - 908
12345